Does diabetes affect [18F]FDG standardised uptake values in lung cancer?

European Journal of Nuclear Medicine

Volumn 29, Issue 10, 2002, Pages 1324-1327

  Gorenberg, Miguel ^a,b   Hallett, William A ^a,b   O'Doherty, Michael J ^a,b  

^a Rebecca Sieff Government Hospital   (Israel)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

2 18F fluoro 2 deoxy D glucose; Diabetes; Lung cancer; Positron emission tomography; Standardised uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HEART MUSCLE; HUMAN; HYPERGLYCEMIA; LUNG CANCER; LUNG INJURY; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; BLOOD; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; QUALITY CONTROL; REFERENCE VALUE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STANDARD; STATISTICS; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUALITY CONTROL; RADIOPHARMACEUTICALS; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS; TISSUE DISTRIBUTION;

EID: 0036384903     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0887-1     Document Type: Article

References (15)

1. National Center for Chronic Disease Prevention and Health Promotion. Diabetes Fact Sheet November 1, 1998. www.cdc.gov/diabetes/pubs/facts98.htm
2. Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN. FDG-PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 1998; 39:1030-1033.
3. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. J Nucl Med 1993; 34:1-6.
4. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumour and normal tissue accumulation of 2-F18-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992; 183:643-647.
5. Langen K-J, Braun U, Rota Kops E, Herzog H, Kuwert T, Nebeling B, Feinendegen LE. The influence of plasma glucose levels on fluorine-18-fluordeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34:355-359.
6. 18F]FDG-PET standardised uptake values in lung cancer. Eur J Nucl Med 2001; 28:919-922.
7. Saunders CAB, Dussek JE, O'Doherty MJ, Maisey MN. Evaluation of fluorine-18-fluordeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 1999; 67:790-797.
8. Thie JA, Hubner KF, Smith GT. The diagnostic utility of the lognormal behavior of PET standardised uptake values in tumours. J Nucl Med 2000; 41:1664-1672.
9. White MK, Bramwell ME, Harris H. Kinetic parameters of hexose transport in hybrids between malignant and nonmalignant cells. J Cell Sci 1983; 62:49-80.
10. White MK, McCubrey JA. Changes in glucose transport associated with malignant transformation. Int J Oncol 1995; 7:701-712.
11. Hahn T, Hofmann W, Reich O, Lang I, Desoye G. Hyperglycemia regulates the glucose-transport system of clonal choriocarcinoma cells in vitro. A potential molecular mechanism contributing to the adjunct effect of glucose in tumour therapy. Int J Cancer 1998; 78:353-360.
12. Zimny M, Bares R, Faß J, Adam G, Cremerius U, Dohmen B, Klever P, Sabri O, Schumpelick V, Buell U. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 1997; 24:678-682.
13. Brown RS, Leung JY, Kison PV, Zasadny KR, Flint A, Wahl RL. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med 1999; 40:556-565.
14. Marom EM, Aloia TA, Moore MB, Hara M, Herndon JE 2nd, Harpole DH Jr, Goodman PC, Patz EF Jr. Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer 2001; 33:99-107.
15. Shepherd PR, Kahn BB. Glucose transporters and insulin action - Implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341:248-257.